Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach

The COVID-19 pandemic poses an ongoing global challenge, and several risk factors make people with multiple sclerosis (pwMS) particularly susceptible to running a severe disease course. Although the literature does report numerous articles on the risk factors for severe COVID-19 and vaccination resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Immovilli, Paolo, Morelli, Nicola, Terracciano, Chiara, Rota, Eugenia, Marchesi, Elena, Vollaro, Stefano, De Mitri, Paola, Zaino, Domenica, Bazzurri, Veronica, Guidetti, Donata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036272/
https://www.ncbi.nlm.nih.gov/pubmed/35466211
http://dx.doi.org/10.3390/neurolint14020030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036272/
https://www.ncbi.nlm.nih.gov/pubmed/35466211
http://dx.doi.org/10.3390/neurolint14020030

Ejemplares similares